Allylescaline
Psychedelic drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Allylescaline?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Allylescaline (4-allyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is closely related in structure to mescaline. Allylescaline was first synthesized by Otakar Leminger in 1972.[1] The compound was later synthesized by Alexander Shulgin and further described in his book PiHKAL.[2] The dosage range is listed as 20–35 mg, and the duration 8–12 hours.[2] Allylescaline produces an entactogenic warmth, an entheogenic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline.
Quick Facts Names, Identifiers ...
Names | |
---|---|
Preferred IUPAC name
2-{3,5-Dimethoxy-4-[(prop-2-en-1-yl)oxy]phenyl}ethan-1-amine | |
Other names
2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethan-1-amine 2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethanamine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C13H19NO3 | |
Molar mass | 237.299 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Close